CAS 842133-18-0
:Canagliflozina
Descrição:
Canagliflozina é um medicamento usado principalmente no manejo do diabetes mellitus tipo 2. Pertence a uma classe de medicamentos conhecidos como inibidores do cotransportador de sódio-glicose 2 (SGLT2), que funcionam prevenindo a reabsorção de glicose nos rins, promovendo sua excreção na urina e reduzindo os níveis de glicose no sangue. A fórmula química de Canagliflozina é C21H25ClO5S, e apresenta um grupo sulfonila, um moiety de clorobenzeno e uma estrutura semelhante à glicose, que contribuem para sua atividade farmacológica. Canagliflozina é tipicamente administrado por via oral e é conhecido por seus benefícios potenciais além do controle glicêmico, incluindo perda de peso e proteção cardiovascular. Efeitos colaterais comuns podem incluir infecções do trato urinário e desidratação. Assim como com qualquer medicamento, é essencial que os pacientes consultem profissionais de saúde para obter aconselhamento personalizado e monitoramento enquanto utilizam Canagliflozina.
Fórmula:C24H25FO5S
InChI:InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1
Chave InChI:InChIKey=XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC=3SC(=CC3)C4=CC=C(F)C=C4)=C(C)C=C2
Sinónimos:- (1S)-1,5-Anhydro-1-C-(3-((5-(4-Fluorophenyl)-2-Thienyl)Methyl)-4-Methylphenyl)-D-Glucitol
- (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-<span class="text-smallcaps">D</span>-glucitol
- 1-(β-<span class="text-smallcaps">D</span>-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene
- 1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- Canaglifozin
- Invokana
- Jnj 24831754Zae
- Jnj 28431754
- Jnj 28431754Aaa
- Ta 7284
- Canagliflozin
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl
- (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
- Canagliflozi
- Cango coluMn net
- Canagliflozin WS
- Canagliflozin, >=98%
- Canaglifozion
- Canagliflozin-D6
- Canagliflozin(TA-7284)
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
18 produtos.
Canagliflozin
CAS:Fórmula:C24H25FO5SPureza:≥ 98.0%Cor e Forma:White to yellow solidPeso molecular:444.52Canagliflozin (Standard)
CAS:Canagliflozin (Standard) is the standard substance of Canagliflozin, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor that inhibits CHO cells expressing mSGLT2, rSGLT2, and hSGLT2 (IC50=2/3.7/4.4 nM). Canagliflozin can be used for the treatment of type II diabetes mellitus (T2DM).Fórmula:C24H25FO5SPeso molecular:444.52Canagliflozin
CAS:<p>Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor. Canagliflozin is used to treat type II diabetes mellitus. Cost-effective and quality-assured.</p>Fórmula:C24H25FO5SPureza:98.01% - >99.99%Cor e Forma:SolidPeso molecular:444.52Canagliflozin
CAS:Produto Controlado<p>Applications Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.<br>References Chao, E. et al.: Drug Fut., 36, 351 (2011); Sha, S. et al.: Diab. Obes. Metab., 13, 669 (2011); Kipnes, M.S.: Clin. Invest., 1, 145 (2011);<br></p>Fórmula:C24H25FO5SCor e Forma:ColourlessPeso molecular:444.521,5-Dihydroxy Canagliflozin
CAS:Produto ControladoFórmula:C24H27FO6SCor e Forma:NeatPeso molecular:462.531Canagliflozin
CAS:Canagliflozin is a drug that has been approved for the treatment of type 2 diabetes. It is an inhibitor of sodium glucose transporter 2 (SGLT2) and reduces blood glucose levels by increasing urinary glucose excretion. Canagliflozin has been shown to have cardiac effects, which may be due to its ability to increase serum natriuretic peptide levels and decrease heart rate. This drug has also been shown to reduce cardiovascular disease activity in patients with type 2 diabetes. Canagliflozin is not active against c. glabrata, but it does inhibit SGLT1 in this organism.Fórmula:C24H25FO5SPureza:Min. 95%Cor e Forma:PowderPeso molecular:444.52 g/mol2'-Deshydroxymethyl-2'-Chloromethyl-6'-methoxy-canagliflozin
CAS:Produto ControladoFórmula:C25H26ClFO5SCor e Forma:NeatPeso molecular:492.9872'-Deshydroxymethyl-2'-Chloromethyl-canagliflozin
CAS:Produto ControladoFórmula:C24H24ClFO4SCor e Forma:NeatPeso molecular:462.961(3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
CAS:Produto ControladoFórmula:C25H27FO6SCor e Forma:NeatPeso molecular:474.542Canagliflozin Tetra-acetyloxy
CAS:Produto ControladoFórmula:C32H33FO9SCor e Forma:NeatPeso molecular:612.662(2R,3R,4R,5R)-1-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2,3,4,5,6-pentahydroxyhexan-1-one
CAS:Produto ControladoFórmula:C24H25FO6SCor e Forma:NeatPeso molecular:460.515









